Evonik Evonik

X

Find the latest news about PROMETHEUS LABS aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
PROMETHEUS LABS
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
9410 Carroll Park Drive 
Telephone
Telephone
(888) 423-5227
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.accesswire.com/viewarticle.aspx?id=770281&lang=en

ACCESSWIRE
27 Jul 2023

https://www.fiercebiotech.com/biotech/prometheus-upsizes-ipo-fueling-chase-pfizer-bowel-disease#:~:text=Prometheus%20upsizes%20IPO%2C%20fueling%20chase%20of%20Pfizer%20in%20bowel%20disease,-by%20Nick%20Paul&text=Prometheus%20Biosciences%20has%20upsized%20its,inflammatory%20bowel%20disease%20(IBD).

Nick Paul Taylor FIERCEBIOTECH
12 Mar 2021

https://endpts.com/prometheus-upsizes-ipo-by-33-ahead-of-pricing-humanigen-secures-loan-of-up-to-80m-to-develop-lenzilumab/

Max Gelman ENDPTS
11 Mar 2021

https://www.fiercepharma.com/marketing/salix-pharmaceutical-president-leaves-bausch-health-for-precision-medicine-gi-company

Beth Snyder Bulik FIERCE PHARMA
06 Sep 2019

http://www.prnewswire.com/news-releases/prometheus-diagnostic-test-validated-in-anticipation-of-us-healthcare-provider-demand-for-celltrions-inflectra-biosimilar-infliximab-300248068.html

PR NEWSWIRE
07 Apr 2016

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/06/in-case-you-missed-it-we-did-prometheus-takes-action-against-fda-over-generic-lotronex-approval-and-.html

Kurt R. Karst FDA LAW BLOG
25 Jun 2015

http://www.patentdocs.org/2015/06/ultramercial-v-wildtangent-petition-for-writ-of-certiorari.html

Michael Borella PATENT DOCS
03 Jun 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY